… first-in-human, randomized, double-blind, placebo-controlled, single ascending dose study to evaluate JK07 in subjects with heart failure with reduced ejection fraction
1. 系统已在2025-06-10 11:33:04对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://www.sciencedirect.com/science/article/abs/pii/S1071916423008485
其他信息:
WH Tang, J Steiner, M Kassi, MT Wheeler…
… of Cardiac Failure, 2024
Elsevier
… A Phase 1 SAD study was conducted to assess safety, pharmacokinetics, and exploratory activity of JK07 in subjects with HFrEF. Eligible subjects were NYHA class II-III, aged 18 - 80 …